Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Ezekowitz

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Journal of the American Heart Association|May 16, 2022
Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-AnalysisAmir Razaghizad, Emily Oulousian, Varinder Kaur Randhawa, et al.
Journal of the American Heart Association|May 6, 2021
Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection FractionMelissa A Daubert, Eric Yow, Huiman X Barnhart, et al.
ESC Heart Failure|January 20, 2025
Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIREMarcin Ufnal, Kathleen Connolly, Marcus Millegard, et al.
The New England Journal of Medicine|March 30, 2020
Vericiguat in Patients with Heart Failure and Reduced Ejection FractionPaul W Armstrong, Burkert Pieske, Kevin J Anstrom, et al.
European Journal of Heart Failure|July 6, 2022
Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trialMichele Senni, Wendimagegn G Alemayehu, David Sim, et al.
JACC. Heart Failure|January 7, 2019
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEFMelissa A Daubert, Kirkwood Adams, Eric Yow, et al.
American Heart Journal|May 27, 2018
Leveraging electronic health records for clinical researchSudha R Raman, Lesley H Curtis, Robert Temple, et al.
Journal of Diabetes and Its Complications|May 2, 2025
Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HFTariq Jamal Siddiqi, Yuxi Liu, Faiez Zannad, et al.
Circulation|January 9, 2020
OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B)D Ian Paterson, George Wells, Fernanda Erthal, et al.
Progress in Cardiovascular Diseases|May 1, 2022
Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT studyMohit Pahuja, Eric S Leifer, John-Ross D Clarke, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Journal of the American Heart Association|May 16, 2022
Clinical Prediction Models for Heart Failure Hospitalization in Type 2 Diabetes: A Systematic Review and Meta-AnalysisAmir Razaghizad, Emily Oulousian, Varinder Kaur Randhawa, et al.
Journal of the American Heart Association|May 6, 2021
Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection FractionMelissa A Daubert, Eric Yow, Huiman X Barnhart, et al.
ESC Heart Failure|January 20, 2025
Relaxin mimetic in pulmonary hypertension associated with left heart disease: Design and rationale of Re-PHIREMarcin Ufnal, Kathleen Connolly, Marcus Millegard, et al.
The New England Journal of Medicine|March 30, 2020
Vericiguat in Patients with Heart Failure and Reduced Ejection FractionPaul W Armstrong, Burkert Pieske, Kevin J Anstrom, et al.
European Journal of Heart Failure|July 6, 2022
Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trialMichele Senni, Wendimagegn G Alemayehu, David Sim, et al.
JACC. Heart Failure|January 7, 2019
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEFMelissa A Daubert, Kirkwood Adams, Eric Yow, et al.
American Heart Journal|May 27, 2018
Leveraging electronic health records for clinical researchSudha R Raman, Lesley H Curtis, Robert Temple, et al.
Journal of Diabetes and Its Complications|May 2, 2025
Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HFTariq Jamal Siddiqi, Yuxi Liu, Faiez Zannad, et al.
Circulation|January 9, 2020
OUTSMART HF: A Randomized Controlled Trial of Routine Versus Selective Cardiac Magnetic Resonance for Patients With Nonischemic Heart Failure (IMAGE-HF 1B)D Ian Paterson, George Wells, Fernanda Erthal, et al.
Progress in Cardiovascular Diseases|May 1, 2022
Assessing race and ethnicity differences in outcomes based on GDMT and target NT-proBNP in patients with heart failure with reduced ejection fraction: An analysis of the GUIDE-IT studyMohit Pahuja, Eric S Leifer, John-Ross D Clarke, et al.
Pageof 11